trending Market Intelligence /marketintelligence/en/news-insights/trending/nYtXGhQVhRykOFlPqlZNWQ2 content esgSubNav
In This List

Intellia Therapeutics director resigns

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Intellia Therapeutics director resigns

Moncef Slaoui resigned as a board member of Intellia Therapeutics Inc. due to a conflict of interest, effective Aug. 7.

Slaoui was added to the board in July. His decision to resign did not result from any disagreement with the company on any matter relating to its operations, policies or practices.